Nissan Chemical Corporation
|Traded as||TYO: 4021|
Nikkei 225 Component
(President and CEO)
|Revenue|| JPY 193.4 billion (FY 2017)|
(US$ 1.8 billion)
| JPY 27.1 billion (FY 2017)|
(US$ 255 million)
Number of employees
|2,583 (consolidated, as of March 31, 2019)|
|Footnotes / references|
The company was founded in 1887 as the Tokyo Jinzo Hiryo (Tokyo Artificial Fertilizer Company) by Jokichi Takamine, Eiichi Shibusawa and Takashi Masuda. Takamine served as chief technical advisor for the company, which later was renamed to Dai Nippon Artificial Fertilizer Company. The company changed the corporate name from Nissan Chemical Industries, Ltd. to Nissan Chemical Corporation on July 1st, 2018.
The four main businesses of Nissan Chemical are Chemicals, Performance Materials, Agricultural Materials and Pharmaceuticals. Among the company's products are LCD display materials such as SUNEVER® and an external antiparasite drug for animals called Fluralaner, which is an active ingredient in the veterinary pharmaceutical "BRAVECTO®", developed by MSD Animal Health (MSD), the global animal health business of Merck & Co., Ltd.
- "Corporate Profile". Nissan Chemical. Retrieved May 8, 2019.
- "About the company". Financial Times. Retrieved May 8, 2019.
- "Company Profile". Nikkei Asian Review. Nikkei Inc. Retrieved May 8, 2019.
- "Nikkei Constituents". NIKKEI. Retrieved November 11, 2010.
- Barbara Molony (1990). Technology and Investment: The Prewar Japanese Chemical Industry. Harvard University - Council on East Asian Studies. p. 27. ISBN 978-0-674-87260-8.
- Daniel H. Inouye (November 15, 2018). Distant Islands: The Japanese American Community in New York City, 1876-1930s. University Press of Colorado. p. 45. ISBN 978-1-60732-793-6.
|This article about a Japanese corporation– or company–related topic is a stub. You can help Wikipedia by expanding it.|